Form 4 for BSX Boston Scientific
Accepted 2025-08-04 00:00:00 ET · period of report 2025-08-01 · accession 0001225208-25-006985 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-04 | 2025-08-01 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | S - Sale+OE | $104.63 | -17.3K | 23.6K | -42% | -$1.81M |
| DM | 2025-08-04 | 2025-08-01 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $24.81 | +17.3K | 39.9K | +77% | +$429.5K |
| DM | 2025-08-04 | 2025-08-01 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | -17.3K | 6,175 | -74% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-01 | S | D | 17,313 | $104.63 | 23,600 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.16 to $105.10, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-08-01 | M | A | 1,009 | $17.26 | 40,913 | D | — | — | |
| 3 | Common | Common Stock | 2025-08-01 | M | A | 6,176 | $24.55 | 36,728 | D | — | — | |
| 4 | Common | Common Stock | 2025-08-01 | M | A | 6,952 | $27.09 | 30,552 | D | — | — | (F2) Includes shares acquired on June 30, 2025 under the Company's Employee Stock Purchase Plan based upon the most current data available. |
| 5 | Common | Common Stock | 2025-08-01 | M | A | 3,176 | $22.71 | 39,904 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-08-01 | M | D | 1,009 | $0.00 | 1,009 | D | $17.26 · — to 2026-02-22 | 1,009 Common Stock | (F6) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |
| 7 | Derivative | Stock Option (Right to Buy) | 2025-08-01 | M | D | 6,952 | $0.00 | 6,952 | D | $27.09 · — to 2028-02-15 | 6,952 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-08-01 | M | D | 3,176 | $0.00 | 3,177 | D | $22.71 · — to 2026-06-01 | 3,176 Common Stock | (F8) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant. |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-08-01 | M | D | 6,176 | $0.00 | 6,175 | D | $24.55 · — to 2027-02-28 | 6,176 Common Stock | (F7) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |